The purpose of this modification is to: a. Change the contracting office from NIH NCI to arpa-H B. Update buyer and contracting officer information C. Update IPP invoicing instructions D. Update the…
Active Definitive Contract Awarded Last action
- Contract number
- 75N91023C00042
- Awardee
-
Trace Biosciences Inc. UEI YGDTEJXJC9G8
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $4,218,974
Award facts
- Opportunity
-
- A Solicitation of the Advanced Research Projects Agency for Health (ARPA-H) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · 75N91023R00041 · Posted May 17, 2023
- Contract value 100% obligated
- $4,218,974.00 Current and potential, with all options
- Completion date 79% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Portland, OR 97239, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Transfer Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $3,574,712 | |
| Supplemental Agreement for work within scope | $45,082 | |
| Original award | $599,180 |
About this award
This is a $4,218,974 firm fixed price contract awarded by the Advanced Research Projects Agency for Health (ARPA-H) to Trace Biosciences Inc., a small business, for the development of intra-operative contrast agents under ARPA-H's SBIR Phase II program. The contract is focused on research and development related to ARPA-H SBIR Topic 04 on intra-operative contrast agents, with performance in Portland, Oregon. It is set aside for total small businesses and runs through September 2027. Trace Biosciences Inc. is a for-profit company that specializes in R&D of fluorescent imaging agents and technologies for medical and surgical applications. This award builds on the company's prior federal grant funding from agencies like the National Institutes of Health for developing near-infrared fluorescence imaging tools to visualize cancer margins and nerves during surgical procedures.
Description
The purpose of this modification is to: a. Change the contracting office from NIH NCI to arpa-H B. Update buyer and contracting officer information C. Update IPP invoicing instructions D. Update the COR information from jenica patterson to miche
Quick answers
Who was awarded contract 75N91023C00042?
75N91023C00042 was awarded to Trace Biosciences Inc. by National Institutes of Health (Department of Health and Human Services) on September 15, 2023.
How much is contract 75N91023C00042 worth?
The government has obligated $4,218,974 on 75N91023C00042.
Was contract 75N91023C00042 competed?
The extent of competition for 75N91023C00042 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award